New Share Issue | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

September 2018

New Share Issue

The board of directors of IDL Biotech AB (publ) has resolved to make a new share issue of approximately SEK 39,4 million before issue costs.

Read the press release here 

AroCell AB (publ) riktar offentligt uppköpserbjudande till aktieägarna i IDL Biotech AB (publ)

IDL Biotech AB uppmärksammar härmed att AroCell AB (publ) idag har lämnat ett uppköpserbjudande till aktieägarna i IDL att överlåta samtliga aktier till AroCell i utbyte mot 0,63 AroCell-aktier för varje aktie i IDL.

IDL Biotech is making progress in Africa

IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company delivers TUBEX® TF.

IDL Biotech

Skip this intro